(Q44236235)

English

A comparison of the efficacy and tolerability of olopatadine hydrochloride 0.1% ophthalmic solution and cromolyn sodium 2% ophthalmic solution in seasonal allergic conjunctivitis

scientific article published in October 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

A comparison of the efficacy and tolerability of olopatadine hydrochloride 0.1% ophthalmic solution and cromolyn sodium 2% ophthalmic solution in seasonal allergic conjunctivitis (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

author name string

Constance H Katelaris

1

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Giorgio Ciprandi

2

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Luc Missotten

3

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

F Darell Turner

4

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Donata Bertin

5

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Gilles Berdeaux

6

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

International Olopatadine Study Group

7

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

publication date

1 October 2002

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Clinical Therapeutics

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

24

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

1561-1575

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Update on ocular allergy treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2980060-1

7 January 2021

based on heuristic

inferred from DOI database lookup

The in vitro and in vivo ocular pharmacology of olopatadine (AL-4943A), an effective anti-allergic/antihistaminic agent

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2980060-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Olopatadine inhibits TNFalpha release from human conjunctival mast cells

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2980060-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibition of cytokine secretion from human leukemic mast cells and basophils by H1- and H2-receptor antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2980060-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of the clinical efficacy and comfort of olopatadine hydrochloride 0.1% ophthalmic solution and nedocromil sodium 2% ophthalmic solution in the human conjunctival allergen challenge model

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2980060-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Combined analysis of two studies using the conjunctival allergen challenge model to evaluate olopatadine hydrochloride, a new ophthalmic antiallergic agent with dual activity

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2980060-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparative study of clinical efficacy and tolerance in seasonal allergic conjunctivitis management with 0.1% olopatadine hydrochloride versus 0.05% ketotifen fumarate

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2980060-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of topical cromolyn sodium in the treatment of vernal keratoconjunctivitis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2980060-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Double-blind comparison of levocabastine eye drops with sodium cromoglycate and placebo in the treatment of seasonal allergic conjunctivitis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2980060-1

7 January 2021

based on heuristic

inferred from DOI database lookup

A double blind placebo controlled group comparative study of ophthalmic sodium cromoglycate and nedocromil sodium in the treatment of vernal keratoconjunctivitis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2980060-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of nedocromil sodium and cromolyn sodium in an experimental model of ocular allergy.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2980060-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of lodoxamide, disodium cromoglycate and fluorometholone on tear leukotriene levels in vernal keratoconjunctivitis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2980060-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Mechanisms and comparison of anti-allergic efficacy of topical lodoxamide and cromolyn sodium treatment in vernal keratoconjunctivitis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2980060-1

7 January 2021

based on heuristic

inferred from DOI database lookup

A useful testing strategy in phase III trials: combined test of superiority and test of equivalence

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2980060-1

7 January 2021

based on heuristic

inferred from DOI database lookup

A stagewise rejective multiple test procedure based on a modified Bonferroni test

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2980060-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibition of histamine-induced human conjunctival epithelial cell responses by ocular allergy drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2980060-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Cromolyn sodium in seasonal allergic conjunctivitis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2980060-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Topical sodium cromoglycate (Opticrom) relieves ongoing symptoms of allergic conjunctivitis within 2 minutes

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2980060-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0149-2918(02)80060-1

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44236235&oldid=2108828552"